The Latest Breaking News from Colon Cancer

Exact Sciences stock rose Friday after the FDA approved the company's next-generation colon cancer detection test, Cologuard Plus.

Scotland head coach Gregor Townsend is set to undertake a gruelling fundraising climbing challenge in memory of former teammate, Tom Smith.

Learn about the concerning surge in colon cancer rates among young adults, linked to diet and lifestyle factors. Screening guidelines have been revised to ...

Six dogs are being trained to detect colon cancer from urine samples.

More than 53,000 Americans are projected to die from colorectal cancer this year. Although colorectal cancer is the second-most common cause of cancer deaths in the United States, it can be cured if caught early. Detecting a tumor as soon as possible can help you get treatment as soon as…

Guardant Health stock jumped Friday after an FDA panel recommended the agency approval Guardant's blood-based colon cancer screening test.

Nationwide colorectal cancer incidence and mortality rates have fallen since 2000, but rates have been increasing among younger adults for several years.

Exact Sciences stock surged Tuesday after the company's colon cancer-screening rival, Freenome, unveiled the results of a pivotal study.

Learn about promising advancements in colon cancer screening methods, including new blood tests and improved stool tests, offering hope for increased early...